TNFRSF13C and breast adenocarcinoma: Furthermore, TCGA datasets showed an elevated fold change of TRIP-Br-3 that was observed in mucinous breast carcinoma (3.060), invasive ductal BRCA (2.250), and intraductal cribriform breast adenocarcinoma (2.202).